Concepedia

Author

Yelena Kemel

Memorial Sloan Kettering Cancer CenterORCID

Also Known As

Kemel, Yelena, MMR IHC was not performed to screen for Lynch syndrome (LS). We present the outcomes of MMR IHC performed outside of a LS screening program., Y. Kemel, Y.M. Kemel, Yelena Kemel, Yelena M. Kemel

246

Publications

3.7K

Citations

29

H-Index

63

Concepts

All Affiliations

Memorial Sloan Kettering Cancer CenterCornell UniversityMolecular Oncology (United States)Kettering UniversitySt. James's Hospital
YK

About

Yelena Kemel is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, pathology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

14

16

833

2

Natural Sciences

2

2

180

3

Engineering

1

1

47

4

Management

1

1

54

5

Nursing

1

1

54

Yelena Kemel

×

48

Publications

3.5K

Citations

29

H-Index

YearCitations

Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer

Alicia Latham, Preethi Srinivasan, Yelena Kemel,

Journal of Clinical Oncology

2018

603

Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing

Diana Mandelker, Liying Zhang, Yelena Kemel,

JAMA

2017

504

Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms

Maeve A. Lowery, Winston Wong, Emmet Jordan,

JNCI Journal of the National Cancer Institute

2018

221

Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma

Maria I. Carlo, Semanti Mukherjee, Diana Mandelker,

JAMA Oncology

2018

191

A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers

Andrea Cercek, Walid K. Chatila, Rona Yaeger,

JNCI Journal of the National Cancer Institute

2021

175

Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors

Elise Fiala, Gowtham Jayakumaran, Audrey Mauguen,

Nature Cancer

2021

156

Human genetic disease caused by de novo mitochondrial-nuclear DNA transfer

Clesson Turner, Christina Killoran, Nick Thomas,

Human Genetics

2003

146

Therapeutic Implications of Germline Testing in Patients With Advanced Cancers

Zsofia K. Stadler, Anna Maio, Debyani Chakravarty,

Journal of Clinical Oncology

2021

145

Cancer Susceptibility Mutations in Patients With Urothelial Malignancies

Maria I. Carlo, Vignesh Ravichandran, Preethi Srinavasan,

Journal of Clinical Oncology

2019

138

The context-specific role of germline pathogenicity in tumorigenesis

Preethi Srinivasan, Chaitanya Bandlamudi, Philip Jonsson,

Nature Genetics

2021

98

Page 1